| 发明名称 |
Methods and Compositions Comprising AMPK Activator (Metformin/Troglitazone) for the Treatment of Myotonic Dystrophy Type 1 (DM1) |
| 摘要 |
The present invention relates to methods and compositions for the treatment of Myotonic Dystrophy type 1 (DM1) with an AMPK activator <eq.metformin or troglizazone>. |
| 申请公布号 |
US2014187595(A1) |
申请公布日期 |
2014.07.03 |
| 申请号 |
US201414152585 |
申请日期 |
2014.01.10 |
| 申请人 |
INSERM (Institut National de la Sante et de la Recherche Medicale) |
发明人 |
Baghdoyan Sandrine;Peschanski Marc;Laustriat Delphine;Gide Jacqueline |
| 分类号 |
A61K31/427;A61K31/155 |
主分类号 |
A61K31/427 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
Paris FR |
